Literature DB >> 33392515

Revealing the impact of structural variants in multiple myeloma.

Ola Landgren1, Francesco Maura2, Even H Rustad1, Venkata D Yellapantula1, Dominik Glodzik3, Kylee H Maclachlan1, Benjamin Diamond1, Eileen M Boyle4, Cody Ashby5, Patrick Blaney4, Gunes Gundem3, Malin Hultcrantz1, Daniel Leongamornlert6, Nicos Angelopoulos6,7, Luca Agnelli8, Daniel Auclair9, Yanming Zhang10, Ahmet Dogan11, Niccolò Bolli12,13, Elli Papaemmanuil3, Kenneth C Anderson14, Philippe Moreau15, Hervé Avet-Loiseau16, Nikhil C Munshi14,17, Jonathan J Keats18, Peter J Campbell6, Gareth J Morgan4.   

Abstract

The landscape of structural variants (SVs) in multiple myeloma remains poorly understood. Here, we performed comprehensive analysis of SVs in a large cohort of 752 multiple myeloma patients by low coverage long-insert whole genome sequencing. We identified 68 SV hotspots involving 17 new candidate driver genes, including the therapeutic targets BCMA (TNFRSF17), SLAMF and MCL1. Catastrophic complex rearrangements termed chromothripsis were present in 24% of patients and independently associated with poor clinical outcomes. Templated insertions were the second most frequent complex event (19%), mostly involved in super-enhancer hijacking and activation of oncogenes such as CCND1 and MYC. Importantly, in 31% of patients two or more seemingly independent putative driver events were caused by a single structural event, demonstrating that the complex genomic landscape of multiple myeloma can be acquired through few key events during tumor evolutionary history. Overall, this study reveals the critical role of SVs in multiple myeloma pathogenesis.

Entities:  

Keywords:  chromoplexy; chromothripsis; hotspots; multiple myeloma; structural variants; templated insertion

Mesh:

Year:  2020        PMID: 33392515      PMCID: PMC7774871          DOI: 10.1158/2643-3230.BCD-20-0132

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  65 in total

1.  Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

Authors:  Y Shou; M L Martelli; A Gabrea; Y Qi; L A Brents; A Roschke; G Dewald; I R Kirsch; P L Bergsagel; W M Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Chromothripsis and Kataegis Induced by Telomere Crisis.

Authors:  John Maciejowski; Yilong Li; Nazario Bosco; Peter J Campbell; Titia de Lange
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

3.  Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.

Authors:  M Bärlund; O Monni; J Kononen; R Cornelison; J Torhorst; G Sauter; A Kallioniemi
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

4.  Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.

Authors:  Xiaoyu Chen; Ole Schulz-Trieglaff; Richard Shaw; Bret Barnes; Felix Schlesinger; Morten Källberg; Anthony J Cox; Semyon Kruglyak; Christopher T Saunders
Journal:  Bioinformatics       Date:  2015-12-08       Impact factor: 6.937

5.  Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.

Authors:  Francesco Maura; Even H Rustad; Venkata Yellapantula; Marta Łuksza; David Hoyos; Kylee H Maclachlan; Benjamin T Diamond; Benjamin D Greenbaum; Gareth Morgan; Alexander Lesokhin; Elli Papaemmanuil; Ola Landgren
Journal:  Leukemia       Date:  2019-12-13       Impact factor: 11.528

6.  Massive genomic rearrangement acquired in a single catastrophic event during cancer development.

Authors:  Philip J Stephens; Chris D Greenman; Beiyuan Fu; Fengtang Yang; Graham R Bignell; Laura J Mudie; Erin D Pleasance; King Wai Lau; David Beare; Lucy A Stebbings; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Michael A Quail; John Burton; Harold Swerdlow; Nigel P Carter; Laura A Morsberger; Christine Iacobuzio-Donahue; George A Follows; Anthony R Green; Adrienne M Flanagan; Michael R Stratton; P Andrew Futreal; Peter J Campbell
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

7.  Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.

Authors:  F Maura; M Petljak; M Lionetti; I Cifola; W Liang; E Pinatel; L B Alexandrov; A Fullam; I Martincorena; K J Dawson; N Angelopoulos; M K Samur; R Szalat; J Zamora; P Tarpey; H Davies; P Corradini; K C Anderson; S Minvielle; A Neri; H Avet-Loiseau; J Keats; P J Campbell; N C Munshi; N Bolli
Journal:  Leukemia       Date:  2017-12-06       Impact factor: 11.528

8.  Accelerated single cell seeding in relapsed multiple myeloma.

Authors:  Heather J Landau; Venkata Yellapantula; Benjamin T Diamond; Even H Rustad; Kylee H Maclachlan; Gunes Gundem; Juan Medina-Martinez; Juan Arango Ossa; Max F Levine; Yangyu Zhou; Rajya Kappagantula; Priscilla Baez; Marc Attiye; Alvin Makohon-Moore; Lance Zhang; Eileen M Boyle; Cody Ashby; Patrick Blaney; Minal Patel; Yanming Zhang; Ahmet Dogan; David J Chung; Sergio Giralt; Oscar B Lahoud; Jonathan U Peled; Michael Scordo; Gunjan Shah; Hani Hassoun; Neha S Korde; Alexander M Lesokhin; Sydney Lu; Sham Mailankody; Urvi Shah; Eric Smith; Malin L Hultcrantz; Gary A Ulaner; Frits van Rhee; Gareth J Morgan; Ola Landgren; Elli Papaemmanuil; Christine Iacobuzio-Donahue; Francesco Maura
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

9.  Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.

Authors:  Isidro Cortés-Ciriano; Jake June-Koo Lee; Ruibin Xi; Dhawal Jain; Youngsook L Jung; Lixing Yang; Dmitry Gordenin; Leszek J Klimczak; Cheng-Zhong Zhang; David S Pellman; Peter J Park
Journal:  Nat Genet       Date:  2020-02-05       Impact factor: 38.330

10.  DELLY: structural variant discovery by integrated paired-end and split-read analysis.

Authors:  Tobias Rausch; Thomas Zichner; Andreas Schlattl; Adrian M Stütz; Vladimir Benes; Jan O Korbel
Journal:  Bioinformatics       Date:  2012-09-15       Impact factor: 6.937

View more
  20 in total

Review 1.  Progress in the Management of Smoldering Multiple Myeloma.

Authors:  Timothy M Schmidt; Natalie S Callander
Journal:  Curr Hematol Malig Rep       Date:  2021-05-13       Impact factor: 3.952

2.  Promiscuous Structural Variants Drive Myeloma Initiation and Progression.

Authors:  P Leif Bergsagel; W Michael Kuehl
Journal:  Blood Cancer Discov       Date:  2020-10-15

3.  Modern Myeloma Therapy + Sustained Minimal Residual Disease-Negative = (Functional) Cure!

Authors:  Ola Landgren; Dickran Kazandjian
Journal:  J Clin Oncol       Date:  2022-06-30       Impact factor: 50.717

4.  Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.

Authors:  Sarah A Holstein; Fotis Asimakopoulos; Abdel Kareem Azab; Giada Bianchi; Manisha Bhutani; Leslie A Crews; Tom Cupedo; Hannah Giles; Sarah Gooding; Jens Hillengass; Lukas John; Shari Kaiser; Lydia Lee; Kylee Maclachlan; Marcelo C Pasquini; Flavia Pichiorri; Nina Shah; Monica Shokeen; Brian R Shy; Eric L Smith; Raluca Verona; Saad Z Usmani; Philip L McCarthy
Journal:  Transplant Cell Ther       Date:  2022-05-21

Review 5.  Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions.

Authors:  Monika Chojnacka; Benjamin Diamond; Ola Landgren; Francesco Maura
Journal:  Semin Oncol       Date:  2022-01-31       Impact factor: 5.385

Review 6.  Chromosome 1q21 abnormalities in multiple myeloma.

Authors:  Timothy M Schmidt; Rafael Fonseca; Saad Z Usmani
Journal:  Blood Cancer J       Date:  2021-04-29       Impact factor: 11.037

7.  Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001.

Authors:  Francesco Maura; Benjamin Diamond; Kylee H Maclachlan; Andriy Derkach; Venkata D Yellapantula; Even H Rustad; Malin Hultcrantz; Urvi A Shah; Jessica Hong; Heather J Landau; Christine A Iacobuzio-Donahue; Elli Papaemmanuil; Shani Irby; Laura Crowley; Michael Crane; Mayris P Webber; David G Goldfarb; Rachel Zeig-Owens; Orsi Giricz; Amit Verma; David J Prezant; Ahmet Dogan; Sohrab P Shah; Yanming Zhang; Ola Landgren
Journal:  Clin Cancer Res       Date:  2021-01-27       Impact factor: 13.801

8.  Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.

Authors:  Bénedith Oben; Guy Froyen; Kylee H Maclachlan; Daniel Leongamornlert; Federico Abascal; Binbin Zheng-Lin; Venkata Yellapantula; Andriy Derkach; Ellen Geerdens; Benjamin T Diamond; Ingrid Arijs; Brigitte Maes; Kimberly Vanhees; Malin Hultcrantz; Elisabet E Manasanch; Dickran Kazandjian; Alexander Lesokhin; Ahmet Dogan; Yanming Zhang; Aneta Mikulasova; Brian Walker; Gareth Morgan; Peter J Campbell; Ola Landgren; Jean-Luc Rummens; Niccolò Bolli; Francesco Maura
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

Review 9.  Genetic Predictors of Mortality in Patients with Multiple Myeloma.

Authors:  Hamza Hassan; Raphael Szalat
Journal:  Appl Clin Genet       Date:  2021-04-29

10.  The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.

Authors:  Neeraj Sharma; James B Smadbeck; Nadine Abdallah; Cinthya Zepeda-Mendoza; Moritz Binder; Kathryn E Pearce; Yan W Asmann; Jess F Peterson; Rhett P Ketterling; Patricia T Greipp; P Leif Bergsagel; S Vincent Rajkumar; Shaji K Kumar; Linda B Baughn
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.